Canada markets close in 3 hours 3 minutes

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.71+0.39 (+4.69%)
As of 12:57PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close8.32
Open8.63
Bid8.65 x 700
Ask8.76 x 500
Day's Range8.17 - 8.73
52 Week Range5.01 - 12.75
Volume316,492
Avg. Volume723,604
Market Cap595.263M
Beta (5Y Monthly)2.48
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

    LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible

  • GlobeNewswire

    Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

    David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s board of directors, effective March 29, 2

  • GlobeNewswire

    Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights

    LONDON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Highlights: COMP360 phase 3 pivotal program ongoing; COMP005 trial top-line data now expected in fourth quarter 2024, COMP006 remains on track for top-line data in mid-2025Teri Loxam to assume Chief Financial Officer role on March 1, 2024Cash position of $220.2 million at December 31, 2023, additional $31.4 million net cash raised to date in first quarter 2024Conference call February 29 at 8:00 am ET (1:00 pm UK) Compass Pathways plc (Nasdaq: CMPS) (“Com